Introduction
Since the first aortic valve xenograft implantation performed by Duran and Gunning in 1964 (1) , constant progress has been made in order to obtain the perfect heart valve substitute. The current alternatives are either mechanical or biological valves, both of which have limited life spans and are associated with bleeding risks (mechanical valves), or degeneration and calcification (biological prosthesis) (2) . Regenerative medicine aims to create living heart valves which would overcome the shortcomings of current alternatives. An ideal tissue engineered heart valve (TEHV) should encompass several characteristics: good hemodynamics, appropriate valve geometry, high durability, non-immunogenicity, non-inflammatory, non-thrombogenic and non-calcifying (1, 3) . Additionally, for young patients, it should have the ability to grow and adapt with the patient's somatic growth (2, (4) (5) (6) .
According to the accepted paradigm, the two main TEHV components are the template, or scaffold and the cells (7) . The scaffold, either biologic or synthetic, should provide an adequate support for cell attachment and an environment for cells which can remodel the scaffold as a response to physiological stimuli. The cells used in TEHV should be easy obtainable, preferably from autologous sources and should have good expandability in vitro. Once seeded within the scaffolds, these will offer the valve viability, growth potential and remodeling capacity. Evaluation of TEHV in vivo is typically performed in an animal model which resembles the physiologic and hemodynamic human characteristics. The gold standard for heart valve in vivo testing is considered the ovine model (9) . In vivo periodical functional examination and histological assessment of the explants should be assessed at the follow-up end-point.
The objective of our study was to compare the in vivo behavior of non-seeded porcine acellular pulmonary valves with those seeded with autologous adipose derived stem cells (ADSCs) implanted in sheep. Valve-derived scaffolds are preferred because of easy accessibility, outstanding hemodynamic properties and the preservation of biological "niches" after decellularization (10) (11) (12) . We also treat acellular scaffolds with penta-galloyl glucose (PGG) for tissue stabilization, to prevent premature scaffold degradation and to reduce calcification (13) (14) (15) . We chose ADSCs because they are easy to obtain in large numbers and because of their plasticity and ability to differentiate into valve cells (7, 16) . The expectation for the stem cells was to differentiate into interstitial valvular cells in vivo and to provide viability and matrix remodeling before extracellular matrix deterioration.
Materials and methods

Acellular scaffolds
Fresh porcine hearts were obtained from a local abattoir and transported to the laboratory on ice. Pulmonary roots were dissected and decellularized by immersion in glass containers on an orbital shaker using a ratio of 100 ml solution / root. Decellularization steps consisted of incubation in 0.02% azide for 24 hours at 22°C, loosening of extracellular matrix and initialization of cell removal (0.05 M NaOH for 1 hours at 22°C), detergents (0.05% sodium dodecyl sulfate, 0.5% Triton X-100, 0.5% Na-Deoxycholate, and 0.2% EDTA in 10 mM TRIS, pH 7.5) for 7 days at at 22°C, with fresh solution changed daily. After rinsing, removal of nucleic acids was performed by incubation in 360 mU/mL deoxyribonuclease and 360 mU/mL ribonuclease in 5 mM MgCl 2 in PBS for 1 day at 37°C. To reduce bio-burden, each extraction step was preceded by a 20 minute 70% ethanol treatment and rinsing with sterile PBS. Finally the roots were incubated in 70% ethanol for 3 hours at 22°C and sterilized in 0.1% peracetic acid in PBS, pH 7.4 for 2 hours at 22°C. To stabilize the valve extracellular matrix, the acellular roots were treated with sterile 0.1% penta galloyl glucose (PGG) in 20% isopropanol, an elastin-binding polyphenol (10) followed by a rapid glutaraldehyde treatment and complete neutralization with glycine to stabilize collagen (17) . Acellular bovine pericardium, also stabilized with PGG, and used for mounting the valves within the conduit, was prepared as described before (18) .
Scaffold evaluation
For histology, samples collected from fresh and decellularized pulmonary cusps and root tissues were fixed in 10% formalin, embedded in paraffin, sectioned at 5 µm and stained with DAPI for nuclei and Hematoxylin & Eosin (H&E) for general structure. DNA was extracted and purified from tissue samples (n=5) using the DN-easy Blood & Tissue Kit (Qiagen) before analysis by Ethidium Bromide agarose gel electrophoresis ( Figure 1 ).
Valvular conduit manufacture
In order to avoid cardio-pulmonary bypass risks, tissue engineered pulmonary valves were implanted in an extra-anatomic position between the right ventricle outflow tract and the pulmo-nary artery, on the beating heart. For this purpose, we first created a valvular conduit by placing the pulmonary valve in a decellularized bovine pericardium tube, resembling the Contegra conduit. Porcine pulmonary roots after decellularization were adjusted, preserving about 0.5 cm of pulmonary wall above the commissures and 0.3 to 0.5 cm of myocardial tissue below the cusps base, maintaining the valvular geometry. The valve proximal and distal ends were sutured into the pericardial tube using 5.0 Polypropylene (Figure 2 ).
Stem cell isolation and seeding
Three weeks before the scheduled implantation, we collected about 5 cm 3 of inter-scapular adipose tissue from each animal in sterile conditions (see animal description below) and isolated ADSCs using a published collagenase-based procedure (19) . The plasticity of sheep ADSCs . E, F, representative low magnification images of H&E stained native pulmonary roots before (E) and after (F) decellularization. G, ethidium bromide agarose gel electrophoresis of DNA extracted and purified from fresh pulmonary (Fr) and decellularized cusps and arteries (n=5 lanes each); results were compared to a genomic DNA standard (Std). Scale bars in A-D are 100 um and in E, F 500 um. was confirmed using differentiation kits (PromoCell, Inc). Cells were propagated for up to 6 passages in the cell culture laboratory and extreme care was exercised to record the source of cells for later autologous implantation. Two days before the scheduled implantation day, the acellular valves were seeded internally with autologous ADSCs by injection of 8-10 million ADSCs in 200 ul PBS into each cusp using a 30G needle (Figure 2, F) . The cell-seeded construct was immersed in DMEM/FBS medium and incubated at 37 o C, 5% CO 2 , 90% humidity before implantation. rd intercostal space provided an optimal exposure of the right ventricle outflow tract (RVOT) and pulmonary artery (PA). After systemic heparinization (1.5 mg/kg) and lateral clamping of the RVOT, the proximal end of the conduit was anastomosed to the right ventricle on the beating heart using a 4.0 Prolene Surjet suture; then the distal end was sutured onto the pulmonary artery in the same manner. After the complete ligation of the native pulmonary artery and unclamping of the RVOT, the conduit placed between the RVOT and the PA became a bypass route for the physiological pulmonary blood flow (Figure 3 ). Postoperatively antalgic, antibiotic, and diuretics were administered for 5 days. Anticoagulant (Fraxiparine 2 x 0.3 ml) therapy was maintained for the first 30 days and anti-aggregant treatment (Aspenter 75 mg/day orally) for the entire length of the study.
Animals and Surgical Procedures
Monthly transthoracic echography was performed under mild sedation, monitoring the valve hemodynamics, leaflet mobility and thickness, and evidence for right heart remodeling. Animals were randomly divided into two groups: Group A (n=6) consisting of animals with implanted decellularized pulmonary xenografts and Group B (n=6) with implanted decellularized pulmonary xenografts seeded internally with autologous ADSCs. Animals were followed for up to 6 months. Explanted valves were analyzed by macroscopic evaluation and histology.
Histological assessment
The tissue fragments were processed according to standard histological techniques. The explanted valves were fixed in neutral formalin, embedded in paraffin, and 5 μm sections were obtained and stained with Hematoxylin and Eosin. As an external control, two decellularized valves and two fresh (non-decellularized) valves were also included for histological evaluation. Additionally, one seeded valve ("time zero") and one unseeded valve were obtained after about 30 minutes of blood flow through the valved conduit, due to intra-operatory death, unrelated to the valve itself.
Results
Decellularization assessment
Histology and DNA analysis showed that our decellularization procedure generated completely acellular cusp and arterial root tissue components. Essentially no nuclei could be found by H&E stain and also by the more sensitive DAPI nuclear staining (Figure 1) . Notably, acellular cusps exhibited large areas of void volumes (pores), where the valve cells used to reside before extraction. In addition, no DNA could be observed on EtBr-stained agarose gel electrophoresis.
Animal evaluation and macroscopic analysis of explanted valves
The early (up to 4 weeks) post-operatory evolution of all animals was favorable, with rapid recovery and without immediate complications or early deaths.
All animals (6/6) in Group A survived to 6 months and had physiologic growth without signs of pulmonary or heart failure. Echocardiographic examination revealed valve leaflets with a preserved structure, no impaired mobility and minimal regurgitation, and no inflammation or calcification.
By comparison, animals in Group B had a different evolution. After about 1 month of follow-up, animals started to present symptoms of right ventricular failure, including dyspnea, pleurisy and ascites. These symptoms were correlated with echographic aspects consisting of cusp thickening and reduced mobility, resulting in valvular insufficiency and right ventricular dilatation (Figure 4 ). Only two sheep survived to term (6 months), the remainder necessitating euthanasia at 1, 2, 3 and 4 months.
Upon macroscopic evaluation, fibrous tissue overgrowth was observed in all valves, covering both distal and proximal anastomoses, the pericardial segments and also slowly enclosing the cusps ( Figure 5 ).
Histological features of the explanted valves
All valves explanted from Group A presented preserved leaflets integrity. Focal or diffuse fibrin deposits were noted on the valves that were exposed to blood flow for only 30 minutes ( Figure 6 ). In Group B valves, the most notable finding was the presence of a 100-300 um thick, well developed fibrous tissue, rich in fibroblasts and connective tissue covering all surfaces (Figure 6 ). In most samples analyzed, the cusp tissues were still intact, but covered in fibrous tissue which limited their mobility. No cells of any kind could be detected in any of the cusp tissue, including lack of any seeded cells, infiltrated inflammatory cells or fibroblasts. In addition, no thrombosis occurred at the cusp surface. Calcification was absent from all cusp tissues analyzed.
Discussions
The main treatment for valvular diseases consists in their surgical replacement, with either mechanical or biological valves. Both these devices have limited life spans and are associated with bleeding risks (mechanical valves) and degeneration (biological prosthesis) (2). Heart valve tissue engineering (HVTE), the science of combining scaffolds, cells and stimuli has the potential to revolutionize the field of valve surgery by providing functional, durable, and viable valves. To date, several approaches have been tested using synthetic and natural scaffolds and a variety of cells and bioreactors, but overall most approaches have not been successful on the long term when tested in animals or human patients as pulmonary or aortic implants (2, (4) (5) (6) . At this stage of research, there are numerous aspects which still need to be studied, optimized or tested before HVTE can make an impact on clinical applications. For example, it is not yet known what the ideal scaffold properties are and whether it should be rapidly degradable, slowly degradable or not degradable at all (2, (4) (5) (6) 20) . Other topics of research are cell sourcing, propagation, whether in vitro differentiation or in vitro mechanical pre-conditioning is needed before implantation, seeding methods, and optimal number of seeded cells.
Rationale and hypothesis
Based on previous experience, we hypothesized that an ideal scaffold would be stabilized acellular porcine roots seeded with autologous stem cells. We chose porcine valves because they closely mimic the human valve anatomy and have a long history of implantation in patients. Notably, porcine valves treated with glutaraldehyde have been implanted in millions of patients and most of them fail by calcification after 3-4 months in sheep or after 10-15 years in humans. The main mechanism of calcification is related to the presence of devitalized cells (21); therefore, acellular valves are good candidates for use as non-calcifying scaffolds. Moreover, it is well known that acellular tissues, if fully decellularized, are not immunogenic, because collagen and elastin are two proteins which have been preserved throughout evolution and thus are not different among species. For this reason, more than 1 million acellular tissues and collagen scaffolds in liquid or solid form have already been implanted in humans without any signs of immunologic rejection (6, 12) . Therefore, acellular valves are not expected to activate the immune system (6).
To test our approach, we completely decellularized porcine pulmonary roots using detergents and enzymes and treated the matrix with PGG, which resulted in functional roots with preserved matrix and mechanical properties. Treatment with PGG, a non-cytotoxic collagen and elastin binding polyphenol reduces susceptibility to collagenase, thus increasing the durability of matrix scaffolds upon implantation (7, 15, 18, 22) . In an attempt to re-cellularize the aortic roots, we isolated sheep ADSCs and seeded them into each of the three cusps by a single injection. To our knowledge this is among the first attempts to revitalize the cusp interstitium with autologous ADSCs. The injection created a single bolus of cells and we hypothesized that these cells would diffuse out and spread throughout the porous cusp interstitium and possibly differentiate into valvular interstitial cells as a response to physiological mechanical stimuli.
Acellular scaffolds and their behavior in vivo
Porcine pulmonary roots were decellularized completely, as shown by histology with DAPI and DNA analysis, the two most accepted criteria for effective decellularization (12). The valve roots were then sutured to a conduit made from acellular pericardium, to generate a valved conduit for RV-PA shunt implantation. This approach was inspired by the Contegra prosthesis used for RVOT reconstruction. We chose acellular pericardium as we have already shown that it is an ideal material for cardiac surgery (17) , and valve tissue engineering (7) and being acellular, it has a very low propensity to calcify in vivo (18) .
Acellular valved conduits treated with PGG were implanted in sheep and followed for up to 6 months (Group A). This has been recognized as the FDA-recommended animal model for testing new designs of mechanical valves, tissue-based bioprosthetic valves, cryopreserved homografts and biohybrid devices (6, 20, (23) (24) (25) (26) (27) (28) . Although not initially developed for tissue engineering, sheep implantation continues to be the animal model of choice for testing of acellular valve scaffolds (29) (30) (31) (32) (33) (34) . The juvenile sheep model is accessible, reproducible, accelerates valve calcification and approximates the human anatomy.
The animals in Group A recovered rapidly from surgery without immediate complications or early deaths, and all animals survived to 6 months, without any signs of pulmonary or heart failure. Valve leaflets preserved their structure and mobility and upon explantation showed no inflammation, thrombosis or calcification. This is important, because glutaraldehyde treated porcine valves calcify heavily when implanted in juvenile sheep (21) and this pathology is associated with inflammation (35) . Notably, there were no signs of immune activation or rejection pointing to the lack of immunogenicity of acellular valves. In addition, despite the complete re-moval of endothelium during decellularization, the exposed basal lamina of the valve and arterial tissues did not encourage long-term thrombogenesis. Overall, it appeared that stabilized acellular valves are a good alternative to the current valve replacements.
Cell-seeded valves and in vivo performance
A second group of animals were implanted with stem cell seeded acellular scaffolds. We chose ADSCs because of their ability to differentiate into valve cells when exposed to valve matrix components and mechanical stimuli (7, 16) . ADSCs were maintained in culture and tested positively for plasticity using standard differentiation kits. Valves were seeded with autologous ADSCs and then implanted in juvenile sheep and monitored for up to 6 months. Animals in Group B had a different evolution from those in Group A. After about 1 month of implantation, all animals developed signs of right ventricular insufficiency and valve cusps appeared thickened and less mobile, leading to dyspnea, pleurisy, and ascites and right ventricular dilatation. The pathology progressed with time, but at different rates for different sheep. The reason for this differential pathology is not well understood. The sheep is known for its propensity to develop excessive fibrotic response to valve implants, and this reaction was considered exuberant when compared to humans (36) (37) (38) . This pathology is not well understood and clearly understudied; it is not clear at this point what initiates the fibrotic reaction, what contributes to its progression and cessation and why certain implants develop very little fibrous overgrowth, while others are completely covered to their full extent. To our knowledge this is the first time that cell seeded valves are compared to their non-seeded controls.
Comparing our results with the published, we hypothesized that the presence of the injected stem cells and cell remnants possibly initiated, exacerbated, and sustained fibrous overgrowth in the RVOT. It is known that ADSCs secrete numerous cytokines and growth factors such as TGF, FGF and TNF and that the efficacy of cell therapy with ASCs is related to their paracrine effects (39, 40) . Therefore it is possible that while in the cusps, the ADSCs have secreted pro-fibrotic agents which stimulated and accelerated the fibrous tissue overgrowth. It is not clear whether this is specific to stem cells and this aspect warrants more investigation.
Potential limitations and future studies
One important aspect which needs further investigation is to find out whether seeded cells actually survived within the valve interstitium, and whether they were not affected by the mechanical stress to which cusps are subjected each cardiac cycle. This includes bending, stretching, and extending forces which could have affected cell viability. It is possible that stem cells are vulnerable to mechanical stress and thus mechanical adaptation and pre-conditioning in vitro before implantation could be needed. In vitro experiments with seeded valves tested in bioreactors are under way in our lab. In addition, a series of experiments should be conducted with fluorescently labeled cells to evaluate their fate after implantation.
Further improvements in cell seeding procedures are also needed, replacing the single injection with methods capable of homogeneously distributing cells within the valve interstitium. Also, orthotopic implantation of valves would be the next animal model to test, since it will provide additional clinical significance. In this respect, since sheep have a tendency to fibrose over valvular implants, alternative large animal models would need to be evaluated.
Conclusions
Acellular stabilized pulmonary roots are excellent valve replacement alternatives. They exhibit adequate hemodynamics and the matrix scaffold is non-immunogenic, non-thrombogenic and non-calcifying in an animal model which typically induces severe degeneration of tissue valves. Notably, cell removal creates pores which could serve as sites for re-cellularization. Seeding these scaffolds with autologous ADSCs was not conducive to tissue regeneration and at least in the current sheep model, the presence of stem cells was associated with extensive fibrotic reactions from the host. Further basic and pre-clinical studies are needed to fully harness the potential of stem cells in heart valve tissue engineering.
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